What is the appropriate starting dose of Paxil (paroxetine) for an adult with anxiety and depression?

Starting Dose of Paxil for Anxiety and Depression

For adults with both anxiety and depression, start Paxil (paroxetine) at 20 mg once daily in the morning for depression, or 10-12.5 mg once daily for anxiety disorders, then titrate based on response and tolerability.

Dosing Based on Primary Indication

The starting dose differs depending on whether you're primarily treating depression versus anxiety:

For Major Depressive Disorder

• Start at 20 mg/day (immediate-release formulation) taken as a single morning dose 1, 2
• This is both the starting dose and the minimal effective dose 3
• For most patients, 20 mg/day will also be the optimal dose 3
• If inadequate response after 1-3 weeks, increase in 10 mg increments weekly up to maximum 50 mg/day 3

For Anxiety Disorders

• Start at 10 mg/day for generalized anxiety or social anxiety 1
• For panic disorder specifically, start even lower at 12.5 mg/day (using controlled-release formulation) 4
• Increase gradually in 10-12.5 mg increments at weekly intervals as tolerated
• Maximum dose for anxiety: 40 mg/day for generalized anxiety 1; up to 50 mg/day for social anxiety 5

Key Prescribing Considerations

Titration Strategy:

• Dose changes should occur at intervals of at least 1 week 4
• A full therapeutic trial requires 4-8 weeks, including at least 2 weeks at the maximum tolerated dose 1
• The full antidepressant effect may be delayed, so patience is essential 4

Special Populations:

• Elderly patients or those with renal/hepatic impairment: Start at 10 mg/day (or 12.5 mg/day of controlled-release), with maximum dose not exceeding 40 mg/day 2, 4
• Older adults are at higher risk for adverse effects, so approximately 50% of the standard adult starting dose is recommended 2

Important Safety Warnings

Paroxetine has notable disadvantages compared to other SSRIs that you should discuss with patients:

• More anticholinergic effects than other SSRIs 1, 2
• Higher rates of sexual dysfunction compared to fluoxetine, fluvoxamine, nefazodone, or sertraline 6, 7
• Greater risk of discontinuation syndrome due to shorter half-life 8, 9
• Should generally be avoided in older adults due to increased anticholinergic burden; prefer citalopram, escitalopram, or sertraline instead 2

Monitor closely for:

• Suicidal ideation/behavior, especially in the first 1-2 weeks and in younger adults 6
• Assess patient status within 1-2 weeks of initiation 6
• If no adequate response within 6-8 weeks, modify treatment 6

Clinical Context

While paroxetine is effective for both depression and anxiety 10, second-generation antidepressants show similar efficacy overall 2, 6. The choice should be based on:

1. Adverse effect profile (paroxetine has more anticholinergic effects and discontinuation issues)
2. Cost (generic available)
3. Patient preference

For treatment-naive patients, consider starting with a better-tolerated SSRI like sertraline, citalopram, or escitalopram first 2, as these have more favorable adverse effect profiles and are preferred agents, particularly in older adults.

If you do prescribe paroxetine, ensure patients understand they should take it consistently (not skip doses due to discontinuation syndrome risk) and should not abruptly stop the medication—taper over 10-14 days when discontinuing 1.